A study of patients with low, medium, or high-risk prostate cancer demonstrated that hypofractionated radiation
therapy delivered using TomoHelical(TM) and simultaneous integrated boost (SIB) provides excellent results in terms of both efficacy and toxicity.
2% of the permitted cohort received hypofractionated radiation
therapy in 2013.
The reason for this discrepancy was the introduction of a hypofractionated radiation
protocol, which was introduced with the aim of reducing waiting times by using higher, but fewer, daily doses of radiation, and thereby decreasing the overall duration of treatment.
2% for women in the hypofractionated radiation group, with approximately 70% of patients having good to excellent cosmetic results.
Long-term results of hypofractionated radiation therapy for breast cancer.
In a multivariate Cox analysis, hypofractionated radiation
therapy reduced the risk of biochemical failure by roughly 70% (hazard ratio 0.
The InTempo System takes the treatment of prostate cancer to an entirely new level, giving clinicians added confidence when delivering high-dose, hypofractionated radiation
associate professor of radiation oncology, University of Wisconsin School of Medicine and Public Health, on a clinical trial to investigate use of the HioArt system for new approaches to hypofractionated radiation
therapy for prostate cancer;
was significantly less expensive than the longer course of treatment: it was between 9.
For example, Timmerman predicted that conventional radiation therapy, which requires six to eight weeks of daily treatments at much lower doses, will largely be replaced by hypofractionated radiation
therapy, which delivers very potent, focused beams of radiation to tumors in five or fewer outpatient sessions of less than 30-60 minutes each.
Clinical experience using hypofractionated radiation
schedules in breast cancer.
i) Common treatment options for prostate cancer include surgery or hypofractionated radiation
therapy such as high dose rate (HDR) brachytherapy.